The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes.
The disclosure generally relates to the novel compounds of formula I, including their salts, which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
Heterocyclic Lithium Amides as Chiral Ligands for an Enantioselective Hydroxyalkylation with <i>n</i>-BuLi
作者:Nicolas Duguet、Sylvain M. Petit、Philippe Marchand、Anne Harrison-Marchand、Jacques Maddaluno
DOI:10.1021/jo8005396
日期:2008.7.1
Chiralheterocyclic structures based on 3-aminopyrrolidines (3APs), 3-aminotetrahydrothiophens (3ATTs), and 3-aminotetrahydrofurans (3ATFs) have been synthesized. The corresponding lithium amides have been evaluated as chiralligands in the condensation of n-BuLi on o-tolualdehyde. The returned levels of induction were in the 46−80% ee range. The cheap and easily prepared 3ATFLi’s turned out to be
Direct Transformation of directing group to important synthetic units would provide a high atom efficiency synthetic approach in synthetic chemistry. Herein, a convenient protocol in synthesis of o-aminobenzaldehyde and benzoxazole...